Animal Anti-rabies Vaccine Market Forecast and Outlook (2024-2031)

Comments · 3 Views

The global animal rabies vaccine market is expected to grow at a CAGR of 4.2% during the forecast period 2024-2031. 

Animal anti-rabies vaccines protect animals from rabies, a fatal viral infection. They stimulate the immune system to produce antibodies against the rabies virus. The main types include inactivated (killed) vaccines, used for domestic animals like dogs and cats, and oral rabies vaccines (ORV), which are delivered to wildlife through bait. Effective vaccination is essential for controlling and preventing rabies in both animals and humans.

Overview

The global animal rabies vaccine market is expected to grow at a CAGR of 4.2% during the forecast period 2024-2031. 

Rabies is a highly fatal zoonotic infection transmitted to humans through bites and saliva from infected animals. Common carriers of the virus include dogs, cats, bats, and raccoons. Rabies is preventable through vaccination, making the immunization of animals a crucial and widely practiced measure for its eradication.

Request for free sample:https://www.datamintelligence.com/download-sample/animal-anti-rabies-vaccine-market

Market Dynamics

Rising Government Initiatives to Eradicate Rabies

  • Rabies is a prevalent zoonotic infection spread to humans through dog bites, and its impact is significant in countries with large dog populations.
  • Endemic countries are actively implementing rabies eradication programs, focusing on mass dog vaccination as a cost-effective strategy to reduce virus transmission.
  • In 2023, the Indian government launched the National Action Plan for Dog Mediated Rabies Elimination by 2030 (NAPRE).
  • The NAPRE initiative aims to achieve zero deaths from dog bite-mediated rabies in India by 2030.
  • A key component of the plan is to achieve at least 70% anti-rabies vaccination coverage among dogs in designated areas annually for three consecutive years.

Get your customized report @https://www.datamintelligence.com/customize/animal-anti-rabies-vaccine-market

Animal Anti-rabies Vaccine Market Segmented

By Type:  Inactivated Vaccine, Recombinant Vector Vaccine

By Animal Type:  Dogs, Cats, Cattle, Goats & Sheep, Equine

By Route of Administration:  Oral, Parenteral

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Competitive Landscape

·         Merck & Co., Inc.

·         Boehringer Ingelheim International GmbH

·         BIO-MED

·         Brilliant Biopharma

·         Zoetis Services LLC

·         Indian Immunologicals Ltd.

·         Virbac

·         Elanco

·         Ceva

·         Biogénesis Bagó

Related Reports

Anti Aging Market

Human Anti-rabies Vaccine Market

Anti-Fatigue Cosmetics Market  

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across

Comments